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(6). The sequence is distinct from a 
small number of sequences derived 
from rabies viruses in Vietnam, which 
suggests that China is a stronger can-
didate for the source of the virus than 
her native country.
Although the case history could 
not provide evidence for interaction 
with a dog while her family was in 
Hong Kong Special Administrative 
Region, rabies was endemic within 
the colony at the time that the pa-
tient’s family was resident. From 1980 
through 1984, 5 human cases were re-
corded (9). Only 2 case-patients had 
clear evidence of a dog bite; histories 
for the remaining 3 cases provided no 
evidence for an animal bite. From 1956 
to 1979, Hong Kong had been free of 
rabies, but the disease had reentered 
the colony shortly after its incidence 
had increased in the neighboring Chi-
nese province of Guangdong. If Hong 
Kong was where the young girl was 
infected, it would indicate an incuba-
tion period of 4.5–6 years.
Such long incubation periods are 
rare for rabies virus infections. An ear-
lier epidemiologic study of 177 cases 
in Amritsar, India, demonstrated that 
rabies developed within 6 months of 
exposure in 90% of human cases (10). 
However, the thorough documentation 
of a small number of cases (1,2) sug-
gests that clinicians need to be aware 
of the importance of including travel 
history over several years in cases of 
unexplained encephalitis. 
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Human Case of 
Bartonella alsatica 
Lymphadenitis 
To the Editor: Lymph node en-
largement is a common medical prob-
lem that is usually caused by bacterial, 
viral, fungal, or protozoal agents (1). 
Malignancies or lymphoproliferative 
diseases are often found, especially in 
elderly patients (1). Bartonella hense-
lae, the main causative agent of cat-
scratch disease (CSD), appears to be 
the most common organism respon-
sible for lymphadenopathy in adults 
and children (1). CSD has also been 
rarely associated with B. quintana (2). 
Recently, the epidemiology of B. quin-
tana as an emerging source of human 
infection has changed because it has 
been isolated from the dental pulp of 
a domestic cat (3). Feral cats have also 
been found to be infected by B. quin-
tana (4). We report a human case of B. 
alsatica lymphadenopathy. 
A 79-year-old woman came to a 
hospital in Agen, France, in Febru-
ary 2008 with a large painless axillary 
mass that she had noticed 10 days ear-
lier. She reported that ≈1 month earlier 
she was scratched on her ﬁ  nger while 
butchering a wild rabbit. On examina-
tion, she did not have any other spe-
ciﬁ  c ﬁ  ndings. Blood cell counts and 
levels of liver enzymes were normal. 
A large necrotic lymph node was sur-
gically removed the next day. Her con-
dition was treated with doxycycline 
(200 mg) for 3 weeks. 
Our laboratory received a frag-
ment of the lymph node of the patient 
and a portion of the rabbit that had been 
cooked, boiled as a terrine, and stored 
in a freezer at –20°C in the home of 
the patient. DNA was extracted from 
these specimens by using a QIAamp 
Tissue Kit (QIAGEN, Hilden, Ger-
many). The DNA was used as a tem-
plate in 3 described PCRs speciﬁ  c for 
a portion of the B. alsatica 16S–23S 
intergenic spacer (ITS) region, ftsZ 
gene, and 16S rDNA (5). All results 
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for the lymph node were positive for 
B. alsatica, and ampliﬁ  cation products 
of the expected size were obtained 
from this extract. Sequences obtained 
shared 100% similarity with the cor-
responding 16S rDNA, ITS region, 
and ftsZ gene fragment of B. alsatica. 
However, the terrine specimen was 
negative for 16S rDNA, the ITS re-
gion, and the ftsZ gene. All negative 
controls showed typical results. B. al-
satica have not been tested or found in 
our laboratory for several years. 
B. quintana subsp. Oklahoma, 
B. henselae subsp. Houston (ATCC 
49882),  B. vinsonii subsp. berkhofﬁ   
(URBVAIE25), B. vinsonii subsp. ar-
upensis (ATCC 700727), and B. alsat-
ica (CIP 105477 T) strains were used 
for immunoﬂ  uorescence and Western 
blotting assays (5). A serum sample 
taken at admission was negative for 
B.  alsatica  by immunoﬂ  uorescence 
assay. This result was accepted be-
cause serologic results may be nega-
tive during the onset of the disease 
(6). Western blotting with Bartonella 
spp. antigens (5) was positive for B. 
alsatica and after adsorption, only B. 
alsatica antigens retained all antibod-
ies (online Appendix Figure, panel 
A, available from www.cdc.gov/EID/
content/14/12/1951-appF.htm).
Formalin-ﬁ  xed,  parafﬁ  n-embed-
ded tissue specimens (3-μm thick) 
were stained with hematoxylin and eo-
sin. Microscopic examination showed 
that the normal architecture of the 
lymph node was destroyed. Histologic 
changes were dominated by large ir-
regular stellate or round granulomas 
with central neutrophil-rich necrosis 
(online Appendix Figure, panel B). 
Granulomas were composed mainly 
of macrophages, whereas neutrophils 
in the necrotic areas were fragmented. 
These granulomas with abscess forma-
tion were similar to those described in 
CSD. Warthin-Starry staining showed 
bacteria in the necrotic center of the 
granulomas (online Appendix Figure, 
panel C).
Immunohistologic staining was 
used to demonstrate B. alsatica in 
the lymph node. Immunohistochemi-
cal analysis was performed by using 
a monoclonal antibody against B. al-
satica with an immunoperoxidase kit 
previously described (7). Brieﬂ  y, after 
deparafﬁ   nization, the tissue section 
was incubated with polyclonal-specif-
ic antibody to B. alsatica (8) diluted 
1:1,000 in phosphate-buffered saline. 
Immunodetection was performed with 
biotinylated immunoglobulins, perox-
idase-labeled streptavidin (HistoStain 
Plus Kit; Zymed, Montrouge, France), 
and amino-ethyl-carbazole as sub-
strate. Slides were counterstained with 
Mayer hematoxylin for 10 min. Loca-
tion of bacteria was superimposable 
on that in the Warthin-Starry–stained 
specimens, and clusters of microor-
ganisms were seen in the inﬂ  amma-
tory areas (online Appendix Figure, 
panel D).
We report lymphadenitis caused 
by B. alsatica. Our ﬁ  nding was con-
ﬁ   rmed by molecular, serologic, and 
staining methods. Bartonella spp. are 
zoonotic agents that infect erythro-
cytes of mammals in which they cause 
chronic bacteremia (9).  B. alsatica 
was ﬁ  rst identiﬁ  ed in 1999 in Alsace, 
France, as an agent of bacteremia in 
healthy wild rabbits (10). However, in 
2006, interest in B. alsatica increased 
when it was considered to be a human 
pathogen because it caused blood-cul-
ture–negative endocarditis in a patient 
who had contacts with rabbits (5). The 
present case conﬁ  rms that B. alsatica 
could be a human pathogen, espe-
cially in persons who live in contact 
with rabbits and should be considered 
a cause of lymphadenopathy.
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Molecular Detection 
of Ehrlichia 
chaffeensis in 
Amblyomma 
parvum Ticks, 
Argentina
To the Editor:  Ehrlichia chaf-
feensis is an obligate intracellular 
bacterium in the family Anaplasma-
taceae. It is considered an emerging 
pathogen in the United States because 
it is the causative agent of human 
monocytotropic ehrlichiosis (1), a ﬂ  u-
like illness that can progress to severe 
multisystem disease and has a 2.7% 
case-fatality rate (2).
In Central and South America, 
human cases of ehrlichiosis with 
compatible serologic evidence have 
been reported in Venezuela, Bra-
zil, Mexico, and Chile, although the 
bacterium has not been isolated (3). 
Recently, molecular evidence of E. 
chaffeensis infection was reported 
for a symptomatic 9-year-old child in 
Venezuela (4). In Argentina, antibod-
ies reactive to E. chaffeensis, or an 
antigenically related Ehrlichia spe-
cies, were detected in human serum 
samples during a serologic survey in 
Jujuy Province, where fatal cases of 
febrile illness were reported (5).
During November–December 
2006, we collected ticks by drag-
ging the vegetation and by examining 
mammal hosts, including humans, in 
semiarid southern Chaco, Argentina, 
Moreno Department, Province of San-
tiago del Estero. Ticks, kept in 70% al-
cohol, were identiﬁ  ed as Amblyomma 
parvum (n = 200), A. tigrinum (n = 
26), and A. pseudoconcolor (n = 13). 
A sample of 70 A. parvum and 1 A. 
tigrinum ticks collected on domestic 
ruminants and canids were subjected 
to PCR and reverse line blot hybrid-
ization by using the TBD-RLB mem-
brane (Isogen Life Science, Maarssen, 
the Netherlands) (6) to look for Ana-
plasma and Ehrlichia spp. DNA was 
extracted from individual ticks by us-
ing the DNeasy Blood and Tissue kit 
(QIAGEN Valencia, CA, USA); sev-
eral negative controls (distilled water) 
for both DNA extraction and PCRs 
were run alongside the samples in ran-
dom order throughout the experiments. 
Primers Ehr-R (5′-CGGGATCCCCA
GTTTGCCGGGACTTYTTCt-
3′) (6) and Ehr-Fint (5′-GGCTCA
GAACGAACGCTG-3′; Inst. Biotec-
nologia, Instituto Nacional de Tec-
nología Agropecuaria, unpub. data) 
were used to amplify a 500-bp fragment 
of the 16S gene of Anaplasma/Ehrli-
chia spp. PCR products were analyzed 
by reverse line blot hybridization , and 
11.3% (95% conﬁ  dence interval [CI] 
= 4.9–21.0) showed a positive signal 
to the speciﬁ  c E. chaffeensis probe: 8 
A. parvum ticks collected from a dog 
(n = 1), a fox (Lycalopex gymnocer-
cus, n = 1), goats (n = 2), and cattle (n 
= 4). No signals to other probes pres-
ent in the membrane were recorded 
(A. phagocytophylum,  A. marginale, 
A. centrale,  A. ovis,  E. ruminatium, 
E. sp. Omatjenne, E. canis). Further 
sequence analysis of 16S fragments 
conﬁ   rmed the result, with our se-
quences showing 99.6% identity with 
the corresponding fragment of the E. 
chaffeensis strain Arkansas 16S gene 
(GenBank accession no. EU826516). 
To better characterize the positives 
samples, we then ampliﬁ  ed variable-
length PCR target (VLPT) of E. chaf-
feensis (7). PCR products of variable 
length were detected by conventional 
gel electrophoresis analysis (Figure). 
Distilled water and R. conorii DNA 
were used as negative controls, and E. 
chaffeensis DNA as the positive con-
trol. The ﬁ  nding was conﬁ  rmed by se-
quence analysis (GenBank accession 
nos. EU826517 and EU826518)
In view of these positive results, 
another set of 108 specimens was test-
ed by E. chaffeensis VLPT PCR: all 
the ticks collected on humans (80 A. 
parvum, 1 A. pseudoconcolor, and 4 A. 
tigrinum), 18 host-seeking A. parvum 
ticks, and 5 A. parvum ticks collected 
on armadillos of the genera Tolypeu-
tes and Chaetophractus. E. chaffeen-
sis was detected in A. parvum ticks 
only: 5 from humans (6.2%; 95% CI 
2.1–14.0; Figure, panel A) and 3 from 
host-seeking ticks (16.7%; 95% CI 
3.6–41.4). In total, E. chaffeensis was 
detected in 9.2% (95% CI 5.4–14.6) 
of tested A. parvum ticks in the study 
area. Of the 16 positive A. parvum, 5 
were infesting humans.
Little is known about E. chaffeen-
sis epidemiology in South America. In 
Brazil, wild marsh deer (Blastocerus 
dichotomus) are suspected to be its 
natural reservoir, but the tick involved 
in the transmission cycle is not known 
(8). In North America, E. chaffeensis 
sp. is maintained principally by the 
lone-star tick, A. americanum, and the 
white-tailed deer (Odocoileus virgin-
ianus) (2). However, the possibility 
of transmission by different ticks and 
infection among other hosts has been 
reported; speciﬁ   c antibodies to E. 
chaffeensis were detected in domes-
tic and wild canids and goats (2), and 
recently experimental infection was 
demonstrated in cattle (9). We did ﬁ  nd 
E. chaffeensis organisms in ticks col-
lected on both wild and domestic ani-
mals, but the possible role of different 
mammals as reservoir hosts deserves 
further investigation. Moreover, the 
ﬁ   nding of polymorphic VLPT gene 
fragments in our sample indicates the 
circulation of E. chaffeensis genetic 
variants in the study area. VLPT re-
petitive sequences vary among isolates 
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